CTOs on the Move

Argon Medical Devices Inc

www.argonmedical.com

 
Argon Medical Devices, Inc. (Argon), founded in 1972 is a leading manufacturer and supplier of single-use Vascular Access Devices. Argon's products are divided into Cardiology, Radiology and Critical Care product lines. Argon supplies disposable
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Mike Gomez
Director of IT Security Profile
Muli Paz
IT Director Business Applications Profile
Dave Hammond
VP, Global IT Profile
John Wideman
Director of Information Security and Governance Profile

Similar Companies

Orthocare Medical Eqp

Orthocare Medical Eqp is a Bedford, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kawasumi Laboratories America Inc

Kawasumi Laboratories America Inc is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InTouch Health

InTouch Health is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.